Free Account Opening + AMC Free Demat
Loading...

Alkem Laboratories IPO vs S H Kelkar IPO

Comparision between Alkem Laboratories IPO and S H Kelkar IPO.

IPO Details

Alkem Laboratories IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while S H Kelkar IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Alkem Laboratories IPO is up to ₹1,349.61 Cr whereas the issue size of the S H Kelkar IPO is up to ₹508.17 Cr. The final issue price of Alkem Laboratories IPO is ₹1,050.00 per share and of S H Kelkar IPO is ₹180.00 per share.

  Alkem Laboratories IPO S H Kelkar IPO
Face Value ₹2 per share ₹10 per share
Issue Price (Lower) ₹1,020.00 per share ₹173.00 per share
Issue Price (Upper) ₹1,050.00 per share ₹180.00 per share
Issue Price (Final) ₹1,050.00 per share ₹180.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 14 shares 80 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹210.00 Cr
OFS Issue Size 1,65,65,161 shares
OFS Issue Size (Amount)
Issue Size Total 1,28,53,442 shares
Issue Size Total (Amount) up to ₹1,349.61 Cr up to ₹508.17 Cr

IPO Timetable

Alkem Laboratories IPO opens on Dec 08, 2015, while S H Kelkar IPO opens on Oct 28, 2015. The closing date of Alkem Laboratories IPO and S H Kelkar IPO is Dec 10, 2015, and Oct 30, 2015, respectively.

  Alkem Laboratories IPO S H Kelkar IPO
Anchor Bid Date
Issue Open Dec 08, 2015 Oct 28, 2015
Issue Close Dec 10, 2015 Oct 30, 2015
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Alkem Laboratories IPO P/E ratio is , as compared to S H Kelkar IPO P/E ratio of .

  Alkem Laboratories IPO S H Kelkar IPO
Financial
ParticularsFor the year/period ended (in Rs. Million)
31 Mar 1531 Mar 1431 Mar 1331 Mar 12
Total Income33,595.2028,395.8024,690.1020,640.10
Profit After Tax (PAT)4,370.904,402.004,667.804,318.10
Promoter Shareholding (Pre-Issue) 70.87% 64.2%
Promoter Shareholding (Post-Issue) 66.23% 56.71%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW 15.4%% 17.7%%

Shares Offered

In the Alkem Laboratories IPO retail investors (RII) are offered 43,94,086 shares while in S H Kelkar IPO retail investors are offered 43,94,086 shares. Qualified institutional buyers (QIB) are offered 25,10,906 shares in Alkem Laboratories IPO and 58,82,397 shares in S H Kelkar IPO.

  Alkem Laboratories IPO S H Kelkar IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 25,10,906 shares 58,82,397 shares
NII 18,83,179 shares 43,05,583 shares
RII 43,94,086 shares 1,00,46,362 shares
Employee 2,98,913 shares
Others
Total 90,87,084 shares 2,02,34,342 shares

Bids Received (Subscription)

Alkem Laboratories IPO subscribed 44.29x in total, whereas S H Kelkar IPO subscribed 27.00x.

  Alkem Laboratories IPO S H Kelkar IPO
QIB (times) 57.19x 25.55x
NII (times) 129.96x 87.38x
Big NII (times)
Small NII (times)
RII (times) 3.17x 1.98x
Employee (times) 0.67x
Other (times)
Total (times) 44.29x 27.00x

Comments

Add a public comment...